Revance Therapeutics Inc (RVNC)

[DewDiligence]

One question and a couple of comments…

Question: What is the source for your statement that Allergan “kicked the tires” between 2014 and 2016?

Comment: You said,

…soon after 2014 IPO the transdermal drug candidate failed and Revance moved quickly to develop injectable drug candidate…

Actually, RVNC was developing both the transdermal (RT001) and injectable (Daxxify f/k/a RT002) products simultaneously, although RT001 came first. RVNC dropped RT001 in Jun 2016, which I viewed as a positive development (#msg-123277118).

Comment: Nobody I know believes the real reason for Dan Browne’s firing was his personal conduct (“HR issues”).

Thanks for posting a capsule summary of RVNC’s history. It should be very helpful for investors and prospective investors who haven’t followed the company since way back.